February 28, 2014
Global Health Technologies Coalition Statement
As a member of Global Health Technologies Coalition, IAVI applauds the historic bipartisan effort, as well as the bold leadership, of both the Congress and Administration in ensuring that the critical Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act of 2008 was passed.
This important legislation to reauthorize the President’s Emergency Plan for AIDS Relief (PEPFAR) is a significant step in addressing the global health challenges of HIV, TB and malaria. The new law not only expands access to existing lifesaving prevention, treatment and care services helping those most at need, it also expands support for the research and development of health technologies such as new drugs, vaccines and microbicides.
In addition, the legislation promotes participation by the United States in negotiations on Advance Market Commitments (AMC) to spur vaccine development and strengthens technical assistance to countries conducting their own research and preparing to introduce new vaccines.
The Global Health Technologies Coalition encourages sustained and increased US commitments to lifesaving global health research and development, and commends members of Congress and the Administration for taking a positive step forward by passing the PEPFAR reauthorization bill.